Cargando…

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

Advances in oncology research have led to identification of tumor-specific biomarkers, some of which are important predictive indicators and ideal targets for novel therapeutics. One such biomarker in non-small cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR). Patients with NS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dae Ho, Srimuninnimit, Vichien, Cheng, Rebecca, Wang, Xin, Orlando, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2015
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614211/ https://www.ncbi.nlm.nih.gov/pubmed/25943319 http://dx.doi.org/10.4143/crt.2014.362

Ejemplares similares

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
por: Bhatt, Vijaya Raj, et al.
Publicado: (2016)

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
por: Butthongkomvong, Kritiya, et al.
Publicado: (2019)

Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
por: Huang, HM, et al.
Publicado: (2023)

Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Sharma, Saniya, et al.
Publicado: (2018)

Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status
por: Linhas, Rita, et al.
Publicado: (2017)

Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes
por: Yin, Xin, et al.
Publicado: (2022)

Rad51 in regulating the radiosensitivity of non‐small cell lung cancer with different epidermal growth factor receptor mutation status
por: Zhong, Xing, et al.
Publicado: (2015)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation
por: Ko, How-Wen, et al.
Publicado: (2022)

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2023)

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
por: Larsen, Stig, et al.
Publicado: (2014)

Analysis of non-small cell lung cancer with miliary lung metastasis in patients harboring epidermal growth factor receptor mutations
por: Chang, Ming-Hung, et al.
Publicado: (2022)

Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
por: Park, Sehhoon, et al.
Publicado: (2016)

Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images
por: Xiao, Zhenghui, et al.
Publicado: (2023)

Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
por: Velazquez, Ana I., et al.
Publicado: (2020)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
por: O’Leary, Connor, et al.
Publicado: (2020)

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
por: Harrison, Peter T., et al.
Publicado: (2020)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series
por: da Cunha Santos, Gilda, et al.
Publicado: (2015)

Lessons Learned: Patient Communication During the Pandemic
por: Wang, EHM, et al.
Publicado: (2021)

Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Lu, Jiameng, et al.
Publicado: (2022)

A Machine Learning-Based Predictive Model of Epidermal Growth Factor Mutations in Lung Adenocarcinomas
por: He, Ruimin, et al.
Publicado: (2022)

Sarcomatoid carcinoma of lung - A case report and review of epidermal growth factor receptor mutation status
por: Kakkar, Aanchal, et al.
Publicado: (2015)

Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma
por: Li, Bo, et al.
Publicado: (2021)

Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancer
por: Hata, Akito, et al.
Publicado: (2017)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

Discordance of Epidermal Growth Factor Receptor Mutation between Brain Metastasis and Primary Non-Small Cell Lung Cancer
por: Kim, Kyung-Min, et al.
Publicado: (2019)

Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer
por: Na, Im Il, et al.
Publicado: (2011)

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
por: Zhang, Liwen, et al.
Publicado: (2017)

Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
por: Chen, Yu, et al.
Publicado: (2021)

COVID-19: Lessons Learned, Lessons Unlearned, Lessons for the Future
por: Hollenberg, Steven M., et al.
Publicado: (2022)

Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancer
por: O’Leary, Connor G, et al.
Publicado: (2018)

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017)

The COVID-19 Pandemic: Changing Lives and Lessons Learned
por: Rohrich, Rod J., et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer
por: Purcell, Emma, et al.
Publicado: (2021)

Osimertinib for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer patients with leptomeningeal metastases and different T790M status
por: Xu, Haiyan, et al.
Publicado: (2021)

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
por: Zhang, Qing, et al.
Publicado: (2015)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
por: Isaka, Tetsuya, et al.
Publicado: (2018)

FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Ishimura, Mariko, et al.
Publicado: (2023)

Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy
por: Pawestri, Aulia Rahmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b1q1i7eu4cc1gvaicjd8ko6tdj